Recent Update on Third-line Helicobacter pylori Eradication
Ji Hyun Kim
Korean J Helicobacter  Up Gastrointest Res. 2015;15(2):89-94.   Published online 2015 Jun 10     DOI: https://doi.org/10.7704/kjhugr.2015.15.2.89
Citations to this article as recorded by Crossref logo
Current Status of the Third-LineHelicobacter pyloriEradication
Jae Ho Choi, Young Joo Yang, Chang Seok Bang, Jae Jun Lee, Gwang Ho Baik
Gastroenterology Research and Practice.2018; 2018: 1.     CrossRef
High and Frequent Dose of Dexlansoprazole and Amoxicillin Dual Therapy for Helicobacter pylori Infections: A Single Arm Prospective Study
Hye Yoon Park, Eun Jeong Kang, Dong Gun Kim, Ki Ju Kim, Jin Woo Choi, Su Youn Nam, Yong Hwan Kwon, Hyun Seok Lee, Seong Woo Jeon
Korean Journal of Gastroenterology.2017; 70(4): 176.     CrossRef
Clinical Efficacy of Gemifloxacin-containing Triple Therapy for First-line Treatment ofHelicobacter pyloriInfection: A Pilot Study
Tae Jun Kim, Jeung Hui Pyo, Hyuk Lee, Yang Won Min, Byung-Hoon Min, Jun Haeng Lee, Jae J. Kim
The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2017; 17(3): 132.     CrossRef